Amgen enters weight loss market with drug that shows 14.5% weight reduction

Early data of Amgen’s weight loss drug MariTide showed comparable weight loss to popular drugs on the market and in development, with patients on the highest dose losing an average of 14.5% of their weight over 85 days.

Amgen tested its molecule in 133 obese but nondiabetic patients in a…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks